Table 2.

The effict of CRO isolation in preoperative donor lungs on outcomes in lung transplant recipients

Outcomes of recipients	CRO isolation positive in donor lungs (n = 9)	Non-CRO isolation positive in donor lungs (n = 36)	P value
DDI (n; %)	8/9 (88.89%)	4/36 (11.11%)	< 0.01
Infection-related death within 60 days (n; %)	7/9 (77.78%)	2/36 (5.56%)	< 0.01
Duration of postoperative ICU treatment (days; mean ± SD)	36.89 ± 20.05	27.86 ± 27.11	0.36
Postoperative consumption of therapeutic antibiotics (cumulative DDDs, mean ± SD)	94.16 ± 58.80	58.57 ± 60.63	0.12

DDI donor-derived infection, CRO carbapenem-resistant organisms, cumulative DDDs the sum of the DDDs of each therapeutic antibiotic used for postoperative lung transplant recipients, DDDs the mass of each antibiotic consumed/ defined daily dose (DDD)